-
1.
公开(公告)号:US10894895B2
公开(公告)日:2021-01-19
申请号:US15739628
申请日:2016-06-27
Inventor: Kyung Sook Kim , Da Yeon Kim , Seung Hun Park , Ja Yong Jang , Moon Suk Kim
IPC: C09D11/14 , C09D11/30 , C09D105/04 , C09D11/08 , C09D105/08 , C09D101/28 , C12N5/00 , A61K47/34 , A61K47/36 , A61K47/38 , A61L27/26 , A61L27/38 , A61L31/04 , A61L31/16 , C09D11/102
Abstract: The present invention provides a two-component bioink including a first solution and a second solution separately, wherein (i) the first solution includes a first biopolymer to which a first chemical functional group is introduced, and the second solution includes a second biopolymer to which a second chemical functional group able to chemically bond with the first chemical functional group is introduced; or (ii) the first solution includes a third biopolymer having a first electrostatic functional group, and the second solution includes a fourth biopolymer having a second electrostatic functional group able to physically bond with the first electrostatic functional group, a 3D biomaterial including the same, and a method for preparing the same.
-
公开(公告)号:US11337929B2
公开(公告)日:2022-05-24
申请号:US16484870
申请日:2018-02-08
Inventor: Moon Suk Kim , Ji Yeon Heo
IPC: A61K31/496 , A61K9/50 , A61K9/00 , A61K45/06
Abstract: A drug delivery formulation for treating a mental illness or a central nervous system disorder is disclosed. The drug delivery formulation includes a microcapsule containing a biodegradable polymer and a drug and a crosslinked hydrogel and a method for preparing the same. The drug delivery formulation can slowly release a drug at a constant rate without a burst of drug release in the early stage of drug administration to maintain a constant blood drug level over a long period of time and thus enjoys the advantage of preventing excessive initial release of drug, thereby obtaining a desirable sustained release profile by single administration without necessity for multiple administrations divided at regular time intervals.
-
公开(公告)号:US11186612B2
公开(公告)日:2021-11-30
申请号:US16858071
申请日:2020-04-24
Inventor: Moon Suk Kim , Sang Dun Choi , Seung Hun Park , Masaud Shah
Abstract: A substance P analog having a progenitor cell or stem cell recruiting activity and a method of recruiting progenitor cells or stem cells using the substance P analog are disclosed. The substance P analog has an effect of recruiting endogenous progenitor cells or stem cells to a wound or disease-occurring site. Thus, the disclosure also describes its use in recruiting progenitor cells or stem cells and a method of regenerating or treating a damaged organ or tissue, or a method of healing a wound.
-
-